Influence of age on outcome after allogeneic hematopoietic cell transplantation: a single center study in patients aged ⩾60.
about
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLAllogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
P2860
Influence of age on outcome after allogeneic hematopoietic cell transplantation: a single center study in patients aged ⩾60.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Influence of age on outcome af ...... er study in patients aged ⩾60.
@en
type
label
Influence of age on outcome af ...... er study in patients aged ⩾60.
@en
prefLabel
Influence of age on outcome af ...... er study in patients aged ⩾60.
@en
P2093
P2860
P356
P1476
Influence of age on outcome af ...... er study in patients aged ⩾60.
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2014.292
P407
P577
2015-01-19T00:00:00Z
P6179
1008870362